Power Check: Itron, Lincoln Electric and Ascendis Pharma
4:42
$
Power Check: Itron, Lincoln Electric and Ascendis Pharma
5 months ago
CNBC
Final trades: Ascendis Pharma, Monolithic Power, the IYC and the GPIQ
1:16
Final trades: Ascendis Pharma, Monolithic Power, the IYC and the …
3 months ago
MSNCNBC
Ascendis Pharma A/S : une nouvelle analyse groupée sur 3 ans confirme des améliorations durables et cliniquement significatives de la fonction rénale chez les adultes atteints d'hypoparathyroïdie traités par TransCon® PTH (Palopegteriparatide)
Ascendis Pharma A/S : une nouvelle analyse groupée sur 3 ans confir…
4 months ago
zonebourse.com
Ascendis Pharma A/S publie ses résultats financiers pour le quatrième trimestre et l'année complète clos le 31 décembre 2025
Ascendis Pharma A/S publie ses résultats financiers pour le quatriè…
1 month ago
zonebourse.com
Ascendis Pharma Q1 Loss Narrows, Revenue Rises
Ascendis Pharma Q1 Loss Narrows, Revenue Rises
10 months ago
marketscreener.com
Why This Small Biotech Is Hammering BioMarin Today
Why This Small Biotech Is Hammering BioMarin Today
Sep 16, 2024
investors.com
Ascendis Pharma Gets Orphan Drug Exclusivity for Hormone Treatment Yorvipath in U.S.
Ascendis Pharma Gets Orphan Drug Exclusivity for Hormone Treatmen…
Sep 11, 2024
marketscreener.com
Ascendis Pharma ADR Clears Technical Benchmark, Hitting 90-P…
4 months ago
investors.com
2:08
Strides Acrolab to buy minority stake in Ascent Pharma
Mar 16, 2010
NDTV
Ascendis Pharma AS 실적 - Investing.com
Aug 19, 2017
investing.com
Ascendis Stock Jumps as FDA Clears Growth-Hormone Treatment
Aug 26, 2021
thestreet.com
0:49
Malattie rare: Topini (Ascendis Pharma), ‘ipoparatiroidismo malat…
11 months ago
MSNAdnkronos
Should You Avoid Ascendis Pharma A/S (ASND)?
Jun 3, 2020
insidermonkey.com
Ascendis Pharma prices upsized IPO at $18, the high end of the range
Jan 28, 2015
nasdaq.com
2:20
Ipoparatiroidismo, a Roma il convegno di APPI e Ascendis Pha…
9 months ago
MSNIl Messaggero
Ascendis Pharma Q2 Loss Widens; FDA Approves Skytrofa To Treat P…
Aug 25, 2021
nasdaq.com
Why Ascendis Pharma (ASND) Stock is a Compelling Investment …
4 months ago
insidermonkey.com
Ascendis Pharma: New InsiGHTS Trial of TransCon hGH (Lonapegs…
Dec 16, 2024
finanznachrichten.de
Ascendis Pharma: New Data Shows Improvements in Growth and Bon…
10 months ago
finanznachrichten.de
FDA Accepts Ascendis Pharma's Supplemental Biologics License A…
3 months ago
finanznachrichten.de
Ascendis Pharma and Novo Nordisk Sign Collaboration for Developme…
Apr 11, 2024
finanznachrichten.de
Ananda Pharma CEO says name change reflects focus on drug dev…
Dec 23, 2024
proactiveinvestors.co.uk
54:35
#ACHONVERSATION on Safety and Efficacy of #Navepegritide for #Ac…
43 views1 month ago
YouTubeGrowing Stronger
0:11
3 Biotech Stocks Wall Street Is Watching 💊📈 #stockmarket #stocks #…
415 views2 weeks ago
YouTubeMike's Money Team
2:07
Growth Hormone Deficiency Market to grow at 5.7% CAGR | Oral GH S…
1 month ago
YouTubeDelveInsight Business Research
15:33
20 Biotech Startups to Watch in 2026: AI, Gene Editing & Obesity […
45 views2 months ago
YouTubeBioMed Nexus
3:55
Interview de Carol BRUCKER, Présidente - Directrice Générale A…
1 week ago
YouTubePharmaceutiquesTV
6:29
YUVIWEL (navepegritide) approved as the first and only once weekly t…
10 views1 week ago
YouTubeMedication Academy
6:38
YUVIWEL - FDA NDA approval - 2026-02-27
10 views1 week ago
YouTubeInside Drug Discovery
Ascendis Wins FDA Approval For Rare Disease Therapy
2 weeks ago
YahooVandana Singh
See more videos
Static thumbnail place holder